Maintenance Therapy of Apatinib After Chemoradiotherapy in Metastatic Nasopharyngeal Carcinoma
Status:
Unknown status
Trial end date:
2019-04-01
Target enrollment:
Participant gender:
Summary
The study is to evaluate the efficacy and safety of Apatinib as maintenace therapy for
Nasopharyngeal Carcinoma With Metastasis after Chemoradiotherapy, including progress free
survival(PFS)、overall survival (OS)、Quality of life score (QoL) and evaluation of drug
safety.